Bozena B. Wrobel

Bozena B. Wrobel

Auto-generated profile, based on publicly available information

Bozena B. Wrobel

Rick and Tina Caruso Department of Otolaryngology—Head and Neck Surgery, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Biological Psychiatry
Verified
Journal Article
Closed access
OEOleg V Evgrafov
Oleg V Evgrafov
CAChris Armoskus
Chris Armoskus
BWBozena B. Wrobel
Bozena B. Wrobel
VSValeria N. Spitsyna
Valeria N. Spitsyna
TSTade Souaiaia
Tade Souaiaia
JKJames A. Knowles
James A. Knowles

29 July 2023 in The Laryngoscope
Verified
Journal Article
Open access
AYAlison J. Yu
Alison J. Yu
BTBenjamin Tam
Benjamin Tam
BWBozena Wrobel
Bozena Wrobel
KHKevin Hur
Kevin Hur
Objective: Temperature‐controlled radiofrequency neurolysis of the posterior nasal nerve (PNN) has been approved for use since 2020. This review synthesized the published data to assess its efficacy for treatment of chronic rhinitis.Data Sources: Pubmed/Medline, Embase, Scopus, Web of Science.Review Methods: A systematic search was conducted with no restrictions on publication years in April 2023. RCTs and prospective investigations that reported the reflective Total Nasal Symptom Score (rTNSS) outcome of radiofrequency neurolysis as a single procedure in chronic rhinitis patients were included. Pooled estimates for change in rTNSS from baseline at 3 months and responder rates (≥30% reduction in baseline rTNSS) at 3 and 6 months were obtained. Other outcomes, such as postnasal drip and cough scores, quality of life (QoL) measures, and adverse events were included for qualitative review.Results: Five studies were included in the systematic review, of which four were included in the meta‐analysis. A total of 284 participants underwent treatment. The pooled change in rTNSS score at 3 months was −4.28 (95% CI, −5.10 to −3.46). The pooled responder rate at 3 months was 77.11% (95% CI, 68.21%–86.01%) and at 6 months 80.80% (95% CI, 70.85%–90.76%). Postnasal drip and cough scores and QoL also improved significantly at follow up. A total of 36 adverse events were reported in 21 (7.4%) patients.Conclusions: The findings from this review suggest that temperature‐controlled radiofrequency neurolysis of the PNN is effective at treating chronic rhinitis symptoms and that it has an overall favorable safety profile. Laryngoscope, 134:507–516, 2024

14 September 2018 in International Forum of Allergy & Rhinology
Verified
Journal Article
Open access
PDF file
RVRicardo Villarreal
Ricardo Villarreal
BWBozena B. Wrobel
Bozena B. Wrobel
LMLuis F. Macias‐Valle
Luis F. Macias‐Valle
GDGreg E. Davis
Greg E. Davis
TPThomas J. Prihoda
Thomas J. Prihoda
PCPhilip G. Chen
Philip G. Chen
Background: Inconsistencies in the nomenclature of structures of the frontal sinus have impeded the development of a validated “reference standard” classification system that surgeons can reliably agree upon. The International Frontal Sinus Anatomy Classification (IFAC) system was developed as a consensus document, based on expert opinion, attempting to address this issue. The purposes of this study are to: establish the reliability of the IFAC as a tool for classifying cells in the frontal recess among an international group of rhinologists; and improve communication and teaching of frontal endoscopic sinus surgery (ESS).Methods: Forty‐two computed tomography (CT) scans, each with a marked frontal cell, were reviewed by 15 international fellowship‐trained rhinologists. Each marked cell was classified into 1 of 7 categories described in the IFAC, on 2 occasions separated by 2 weeks. Inter‐ and intrarater reliability were evaluated using Light's kappa (κ), the interclass correlation coefficient (ICC), and simple proportion of agreement.Results: Interrater reliability showed pairwise κ values ranging from 0.7248 to 1.0, with a mean of 0.9162 (SD, 0.0537). The ICC was 0.98. Intrarater reliability showed κ values ranging from 0.8613 to 1.0, with a mean of 0.9407 (SD, 0.0376). The within‐rater ICC was 0.98.Conclusion: Among a diverse sample of rhinologists (raters), there was substantial to almost perfect agreement between raters, and among individual raters at different timepoints. The IFAC is a reliable tool for classification of cells in the frontal sinus. Further outcome studies are still needed to determine the validity of the IFAC.

24 December 2023 in Annals of Otology, Rhinology & Laryngology
Verified
Journal Article
Closed access
BTBenjamin Tam
Benjamin Tam
JLJessica Le
Jessica Le
DTDennis M. Tang
Dennis M. Tang
AWArthur W. Wu
Arthur W. Wu
MHMartin L. Hopp
Martin L. Hopp
KHKevin Hur
Kevin Hur
Objectives: Among patients with chronic rhinosinusitis (CRS), gender differences in epidemiology as well as quality of life have been reported. However, whether gender differences in endoscopic sinus surgery (ESS) preoperative concerns exist is unclear. Methods: CRS patients undergoing ESS at 3 tertiary care centers in Los Angeles completed the validated Western Surgical Concern Inventory - ESS assessing ESS preoperative concerns. Results: Of the 75 patients included, female patients expressed greater concern than male patients in regard to nasal packing, undergoing anesthesia, impact of surgery on daily activities, and pain and discomfort following surgery. Conclusion: This study suggests there are gender differences in ESS preoperative concerns and otolaryngologists should be aware of these possible concerns during preoperative discussions.